ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag us supreme court genetics genomics

Courts Re-Examining Gene Patents
Sabrina Richards | Mar 28, 2012 | 2 min read
The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.
Opinion: On Patenting Genes
Joan Ellis | Jun 18, 2013 | 5 min read
The scientific community and the impact of the Myriad Genetics Supreme Court decision
Payday for US Plant Scientists
Peg Brickley | Jan 20, 2002 | 4 min read
A Dec. 10 ruling from the US Supreme Court that validates patents on genetically engineered plants re-ignited the debate over the politics of property rights in the life sciences. In a case involving the leading seed-corn producer, Pioneer Hi-Bred International Inc. of Des Moines, Iowa, the Court endorsed the US Patent and Trademark Office's 1985 decision to issue broad utility patents on plants.1 The patent office based its decision on earlier rulings that "anything under the sun made by man" i
Another Legal Setback for Myriad
Kerry Grens | Mar 11, 2014 | 2 min read
A judge declines Myriad Genetics’s request to block its competitors from selling BRCA tests.  
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018 | 2 min read
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
Genome patents need purpose
Andrea Gawrylewski | Aug 4, 2008 | 2 min read
The British High Court's rejection linkurl:last week;http://www.the-scientist.com/blog/display/54909/ of a biotech company's patent on the genetic sequence coding for a therapeutically important protein may be a warning for other biotechs who hold patents on portions of the human genome. The court ruled last week that a patent held by Human Genome Sciences since the mid 1990s was invalid because at the time the company applied for the patent they hadn't demonstrated a practical use. The patent
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016 | 10 min read
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Gene Patents Decision: Everybody Wins
Jeffrey M. Perkel | Jun 18, 2013 | 5 min read
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Week in Review, June 10–14
Bob Grant | Jun 14, 2013 | 4 min read
Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration
Scientific Advances Carry A Moral Price Tag
Ira Glasser | May 26, 1991 | 3 min read
The history of science is full of examples of advances that seemed marvelous at first, but later turned out to have unexpected effects. Synthetic chemicals--detergents, for example--were produced and used on a large scale before anyone recognized the problems caused by their inability to biodegrade. A similarly adverse situation manifests itself today in the depletion of the ozone layer. The problem is more troubling when the effects of scientific development are legal or sociological. In such

Run a Search

ADVERTISEMENT